Latest | Instant news on finance, ETFs, IPOs etc. _第136页

07:44

【Eastroc Beverage (09980.HK): Proposed Foreign Exchange Derivatives Transactions with Maximum Contract Value Capped at RMB 1 Billion】NewTimeSpace News: Eastroc Beverage announced on 30 July that the Company intends to conduct foreign exchange derivatives transactions with financial institutions including banks. The maximum contract value held on any single trading day shall not exceed RMB 1 billion or equivalent foreign currencies, while the ceiling for margins and premiums deployed shall not surpass RMB 100 million.

Tag： Eastroc Beverage 09980.HK

07:40

【Chifeng Jilong Gold Mining Group (06693.HK): Significant Resource Update for Sepan SND Project of Vientiane Mining in Laos, Total Gold Equivalent Metal Volume Reaches 260 Tonnes】NewTimeSpace News: Chifeng Jilong Gold Mining Group announced on 30 July that the mineral resource estimate of the Sepan SND porphyry gold-copper project operated by Vientiane Mining in Laos has been updated. The combined measured and indicated total metal volume stands at 260 tonnes of gold equivalent, representing an increase of approximately 143% compared with the initial disclosure.

Tag： Chifeng Jilong Gold Mining Group 06693.HK

07:31

【Yangtze Optical Fibre and Cable Joint Stock Limited Company (06869.HK): Proposed Acquisition of 25% Equity Stake in Yangtze Optical Shanghai at Consideration of EUR 12 Million】NewTimeSpace News: Yangtze Optical Fibre and Cable announced on 30 July that the Company has entered into an equity transfer agreement with Draka Comteq B.V. to acquire a 25% equity stake in Yangtze Optical Fibre and Cable (Shanghai) Co., Limited at a consideration of EUR 12 million.

Tag： Yangtze Optical Fibre and Cable Joint Stock Limited Company 06869.HK

07:26

【Sigenergy Technology (06656.HK): Interim Revenue Forecast to Surge 240%–270%, Net Profit to Rise 190%–210%】NewTimeSpace News: Sigenergy Technology announced on 30 July that the Group expects its revenue for the first half of 2026 to range from approximately RMB 9.5 billion to RMB 10 billion, representing a year-on-year growth of roughly 240% to 270%; its net profit is projected at about RMB 2.35 billion to RMB 2.45 billion, up 190% to 210% year-on-year.

Tag： Sigenergy Technology 06656.HK

07:21

【HSBC Holdings plc (00005.HK): Disposal of Australian Residential and Personal Loan Portfolio for A$36 Billion】NewTimeSpace News: HSBC Holdings plc announced on 31 July that HSBC Bank Australia, its indirect wholly-owned subsidiary, agreed to sell its Australian residential and personal loan portfolio to an entity affiliated with a Blackstone-managed fund at an aggregate consideration of approximately A$36 billion (around US$25 billion).

Tag： HSBC Holdings plc 00005.HK

21:56

【Shanghai TopNC (07688.HK): Authorized to Repurchase Up to 38.13 Million H Shares; Proposes On-Market Buyback Capped at HK$300 Million】NewTimeSpace News: Shanghai TopNC announced that its board, authorized by shareholders at the 29 July 2026 EGM to repurchase up to 38.13 million H shares (10% of issued H shares), proposes to conduct on-market buybacks capped at HK$300 million using internal resources rather than IPO proceeds; the board views this as a demonstration of confidence in the company's business outlook, with repurchased shares to be cancelled or held in treasury while maintaining the required public float.

Tag： Shanghai TopNC 07688.HK

21:43

【DEEPEXI TECH(01384.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 31.92 million, loss narrowed by 89.65% YoY】July 30, 2026, DEEPEXI TECH(01384.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 283.99 million, increased by 114.97% YoY

Tag： DEEPEXI TECH 01384.HK

21:43

【NEW AMANTE (08412.HK) plans to issue in total 24.45 million shares by subscription, with estimated net proceeds of HKD 5.89 million】NEW AMANTE (08412.HK) plans to issue in total 24.45 million shares by subscription, with estimated net proceeds of HKD 5.89 million.

Tag： NEW AMANTE 08412.HK

20:47

【Shaw Brothers (00953.HK): No Conditions Yet Satisfied for Potential Extreme Transaction to Acquire CMC MOON; Due Diligence and Circular Preparation Ongoing】NewTimeSpace News: Shaw Brothers provided a monthly update on its potential extreme transaction to acquire the entire issued share capital of CMC MOON HOLDINGS LIMITED, stating that due diligence and circular preparation are ongoing and PRC filing and approval procedures are being fulfilled, though no conditions have been satisfied as of the announcement date; the board reminded shareholders that the acquisition remains subject to multiple conditions including independent shareholder approval and an extreme transaction determination, and may not proceed.

Tag： SHAW BROTHERS 00953.HK

20:12

【Sunshine Lake Pharma (06887.HK): Insulin Degludec Injection Receives NMPA Marketing Approval; Domestic Insulin Portfolio Expands to 6 Products】NewTimeSpace News: Sunshine Lake Pharma announced NMPA approval for its self-developed Insulin Degludec Injection in two specifications, expanding its domestic insulin portfolio to six products spanning second- to fourth-generation therapies; the group also disclosed that its insulin aspart/degludec dual formulation is under marketing review and HEC-151 has entered Phase I trials, following its insulin glargine becoming the first Chinese-developed product of its kind approved by the FDA in April 2026.

Tag： SUNSHINE PHARMA 06887.HK

19:12

【HAIZHI TECH GP(02706.HK) closed 19.09% lower, the Hang Seng Software & Services Sector saw divergent trends】By the close of trading on Jul 30, 2026, HAIZHI TECH GP(02706.HK) saw a loss of 19.09% in its share price, closing at HKD 21.44. During the session, it reached an intraday high of HKD 26.5

Tag： HAIZHI TECH GP 02706.HK

19:12

【CFMEE(09630.HK) closed 17.39% lower, the Hang Seng Industrial Engineering Sector saw divergent trends】By the close of trading on Jul 30, 2026, CFMEE(09630.HK) saw a loss of 17.39% in its share price, closing at HKD 229. During the session, it reached an intraday high of HKD 276.2 and touched an intraday low of HKD 228.

Tag： CFMEE 09630.HK

19:12

【ANKER(00668.HK) closed 10.25% higher, the Hang Seng Household Goods & Electronics Sector saw divergent trends】By the close of trading on Jul 30, 2026, ANKER(00668.HK) saw a gain of 10.25% in its share price, closing at HKD 118.3. During the session, it reached an intraday high of HKD 120.8 and touched an intraday low of HKD 104.7.

Tag： ANKER 00668.HK

19:11

【Z.AI(02513.HK) closed 16.55% lower, the Hang Seng Software & Services Sector saw divergent trends】By the close of trading on Jul 30, 2026, Z.AI(02513.HK) saw a loss of 16.55% in its share price, closing at HKD 862. During the session, it reached an intraday high of HKD 1048 and touched an intraday low of HKD 840.

Tag： Z.AI 02513.HK

19:11

【FOREST CABIN(02657.HK) will spend HKD 15.24 million to repurchase 284.2 thousand shares on Jul 30, 2026】FOREST CABIN(02657.HK) will spend HKD 15.24 million to repurchase 284.2 thousand shares on Jul 30, 2026 .

Tag： FOREST CABIN 02657.HK

19:11

【PLOVER BAY TECH(01523.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 27.72 million, YoY increase of 27.94%】July 30, 2026, PLOVER BAY TECH(01523.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 74.6 million, increased by 18.51% YoY

Tag： PLOVER BAY TECH 01523.HK

18:03

【Sirnaomics-B (02257.HK): First Patient Dosed in Phase 2 Clinical Trial of STP705 for Medical Aesthetics】NewTimeSpace News: Sirnaomics Ltd. (02257.HK) announced that the first patient has been successfully dosed in a Phase 2 multicenter clinical trial evaluating STP705 for medical aesthetics. The trial aims to systematically assess the clinical efficacy of STP705 in achieving targeted subcutaneous fat reduction through local administration, leveraging the Group's proprietary PNP oligonucleotide delivery platform, which enables site-specific gene regulation to drive controlled adipocyte clearance.

Tag： SIRNAOMICS-B 02257.HK Medical Aesthetics Clinical Trial

17:59

【CANbridge-B (01228.HK): GORYNIN® (Velaglucerase Beta) Initiates Registration and Commercialization Preparations in North Africa, Advancing Global Gaucher Disease Market Strategy】NewTimeSpace News: CANbridge Pharmaceuticals Inc. (01228.HK) announced on July 30 that GORYNIN®, a treatment for Gaucher disease, has commenced registration and commercialization preparations in the North African market. GORYNIN® is the Company's first self-developed enzyme replacement therapy, approved in China in May 2025. The Company stated it will pursue a global market strategy, though it has yet to generate any sales revenue from North Africa, where the registration process remains subject to regulatory approval.

Tag： CANBRIDGE-B 01228.HK Commercialization

17:54

【Henlius (02696.HK): First Patient Dosed in Phase 1 Trial of Trispecific Antibody HLX3902 Targeting STEAP1×CD3×CD28】NewTimeSpace News: Shanghai Henlius Biotech, Inc. (02696.HK) announced that the first patient has been dosed in a Phase 1 clinical study in China for its self-developed HLX3902 Injection, a STEAP1×CD3×CD28 trispecific antibody, for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and other advanced solid tumors. To date, no trispecific antibody of the same target class has been approved for marketing globally.

Tag： HENLIUS 02696.HK Clinical Trial

17:49

【MGM China (02282.HK): Executive Director Ms. Liu Zhenni Appointed as Chief Financial Officer】NewTimeSpace News: MGM China Holdings Limited (02282.HK) announced that Executive Director Ms. Liu Zhenni will be appointed as Chief Financial Officer with effect from August 1, 2026.

Tag： MGM CHINA 02282.HK Appointment CFO